Effect of poly(lactic-co-glycolic acid) contact on maturation of murine bone marrow-derived dendritic cells

Journal of Biomedical Materials Research - Part A

Volumn 80, Issue 1, 2007, Pages 7-12

  Yoshida, Mutsumi ^a   Mata, Jessica ^a   Babensee, Julia E ^a  

^a Emory University   (United States)

Author keywords

Adjuvant; Dendritic cells; Murine; Poly(lactic co glycolic acid)

Indexed keywords

BLOOD; CELLS; IMMUNOLOGY; INORGANIC ACIDS; MOLECULAR BIOLOGY; POLYMERS; TISSUE CULTURE;

DENDRITIC CELLS; MURINE; POLY(LACTIC-CO-GLYCOLIC ACID);

BIOMATERIALS;

ADJUVANT; B7 ANTIGEN; BIOMATERIAL; CD86 ANTIGEN; CYTOKINE; INTERLEUKIN 6; POLYGLACTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL CONTACT; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; FILM; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD86; BIOCOMPATIBLE MATERIALS; BONE MARROW CELLS; CELLS, CULTURED; DENDRITIC CELLS; GLYCOLATES; HUMANS; INTERLEUKIN-6; MATERIALS TESTING; MICE; TISSUE ENGINEERING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845476239     PISSN: 00219304     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30832     Document Type: Article

References (36)

1. Mikos AG, McIntire LV, Anderson JM, Babensee JE. Host response to tissue engineered devices. Adv Drug Deliv Rev 1998;33:111-139.
2. Rihova B. Immunocompatibility and biocompatibility of cell delivery systems. Adv Drug Deliv Rev 2000;42:65-80.
3. Tang L, Eaton JW. Inflammatory responses to biomaterials. Am J Clin Pathol 1995;103:466-471.
4. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996;17:93-102.
5. Eldridge JH, Staas JK, Meulbroek JA, McGhee JR, Tice TR, Gilley RM. Biodegradable microspheres as a vaccine delivery system. Mol Immunol 1991;28:287-294.
6. Hutchinson FG, Furr BJA, editors. Biodegradable Polymers in Sustained Release of Polypeptides. New York:Plenum; 1986.
7. Mikos AG, Temenoff JS. Formation of highly porous degradable scaffolds for tissue engineering. Electronic J Biotech 2000;3:114-119.
8. Ertl HC, Varga I, Xiang ZQ, Kaiser K, Stephens L, Orvos LJ. Poly (DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines. Vaccine 1996;14:879-885.
9. Walker KB, Xing DK, Sesardic D, Corbel MJ. Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheres. Dev Biol Stand 1998;92:259-267.
10. Raghuvanshi RJ, Mistra A, Talwar GP, Levy RJ, Labhasetwar V. Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid. J Microencapsul 2001;18:723-732.
11. Singh M, O'Hagan D. Advances in vaccine adjuvants. Nat Biotechnol 1999;17:1075-1081.
12. Hunter RL. Overview of vaccine adjuvants: Present and future. Vaccine 2002;20:S7-S12.
13. Jilek S, Ulrich M, Merkle HP, Walter E. Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells. Pharm Res 2004;21:1240-1247.
14. Yoshida M, Babensee JE. Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. J Biomed Mater Res A 2004;71:45-54.
15. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
16. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
17. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J Exp Med 1995;182:389-400.
18. Winzler C, Rover P, Rescigno M, Granucci F, Penna G, Adorini L, Zimmermann VS, Davoust J, Ricciardi-Castagnoli P. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 1997;185:317-328.
19. Flo TH, Ryan L, Latz E, Takeuchi O, Monks BG, Lien E, Halaas O, Akira S, Skjak-Braek G, Golenbock DT, Espevik T. Involvement of toll-like receptor TLR2 and TLR4 in cell activation by mannuronic acid polymers. J Biol Chem 2002;277:35489-35495.
20. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal and activate the NFκB pathway. Int Immunol 2000;12:1539-1546.
21. Bethke K, Staib F, Distler M, Schmitt U, Jonuleit H, Enk AH, Galle PR, Heike M. Different efficiency of heat shock proteins (HSP) to activate human monocytes and dendritic cells: Superiority of HSP60. J Immunol 2002;169:6141-6148.
22. Johnson GB, Brunn GH, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002;168:5233-5239.
23. Termeer C, Hennies J, Voith U, Ahrens T, Weiss JM, Prehm P, Simon JC. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000;165:1863-1870.
24. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J Exp Med 2002;195:99-111.
25. Wake MC, Gerecht PD, Lu L, Mikos AG. Effects of biodegradable polymer particles on rat marrow-derived stromal osteoblasts in vitro. Biomaterials 1998;19:1255-1268.
26. Ishaug SL, Crane GM, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 1997;36:17-28.
27. Inaba K, Inaba M, Romaru N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992;176:1693-1702.
28. Akira S, Takeda K, Kaisho T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675-680.
29. Yoshida M, Babensee JE. Molecular aspects of microparticle phagocytosis by dendritic cells. J Biomater Sci Polym Ed. In press.
30. Waeckerle-Men Y, Scandella E, Uetz-Von Allmen E, Ludewig B, Gillessen S, Merkle HP, Gander B, Groettrup M. Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co- glycolide) microspheres for immunotherapy. J Immunol Methods 2004;287:109-124.
31. Elamanchili P, Diwan M, Cao M, Samuel J. Characterization of poly(DL-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine 2004;22:2406-2412.
32. Newman KD, Elamanchili P, Kwon GS, Samuel J. Uptake of poly(DL-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo. J Biomed Mater Res 2002;60:480-486.
33. Sun H, Pollock KG, Brewer JM. Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro. Vaccine 2003;21:849-855.
34. Yoshida M, Babensee JE. Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation. J Biomed Mater Res. In press.
35. Kranzer K, Sollner L, Aigner M, Lehn N, Deml L, Rehli M, Schneider-Brachert W. Impact of Helicobacter pylori virulence factors and compounds on activation and maturation of human dendritic cells. Infect Immun 2005;73:4180-4189.
36. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J Immunol 2000;165:618-622.